Skip to main content
. 2018 Feb 8;13(2):e0192529. doi: 10.1371/journal.pone.0192529

Table 1. Patient characteristics by chemotherapy course.

    Induction I (N = 1600) Induction II (n = 1249) Intensification I (n = 990) Intensification II (n = 671) Intensification III (n = 392)  
  % % % %) %) p-value
Gender 0.9119
Male 52.3 52.2 50.8 50.8 52.6
  Female 47.7 47.8 49.2 49.2 47.4  
Age, years 0.5271
<1 11.7 12.2 11.8 11.6 12.5
1 to < 5 24.7 25.9 26.3 28.8 31.9
5 to <10 17.0 16.3 16.6 16.2 14.8
10 to <15 26.0 26.4 26.3 25.8 25.5
  15 to <20 20.6 19.3 19.1 17.6 15.3  
Race 0.9788
White 70.6 71.4 71.5 73.0 73.2
Black 13.5 12.8 12.7 11.5 13.3
Asian 3.9 3.7 3.3 3.6 2.8
  Other 11.9 12.1 12.4 11.9 10.7  
Insurance 0.9901
Private 41.9 42.0 42.0 43.2 41.1
Public 42.7 41.5 41.8 41.7 42.3
  Other 15.4 16.6 16.2 15.1 16.6  
Diagnosis Year <0.0001
2000–2001 0.3 0.3 0.0 0.0 0.0
2002–2003 1.8 2.3 0.9 0.4 0.0
2004–2005 16.1 17.5 15.9 15.2 22.2
2006–2007 18.7 20.0 20.5 22.1 28.8
2008–2009 20.8 22.3 23.6 21.8 28.3
2010–2011 21.6 21.1 21.6 21.6 19.4
  2012–2014 22.9 19.0 18.3 18.9 1.3  
Parenteral Nutrition 31.0 16.8 17.2 27.6 22.7 <0.0001
ICU level care 15.9 4.4 7.2 11.2 10.5 <0.0001